Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

NCT01175226 is registered in ClinicalTrials.gov with Biota Scientific Management Pty Ltd as lead sponsor.

NCT NCT01175226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01175226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
Lead sponsor
Biota Scientific Management Pty Ltd
Phase
Phase 2
Overall status
Completed
Start date
August 31, 2010
Completion date
March 31, 2012
Enrollment
300 (actual)
Sites
43

Conditions

As the registry lists them; a condition with its own page is linked.

rhinovirus